109 related articles for article (PubMed ID: 20926128)
1. Development and in vivo evaluation of an oral drug delivery system for paclitaxel.
Iqbal J; Sarti F; Perera G; Bernkop-Schnürch A
Biomaterials; 2011 Jan; 32(1):170-5. PubMed ID: 20926128
[TBL] [Abstract][Full Text] [Related]
2. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide.
Iqbal J; Shahnaz G; Perera G; Hintzen F; Sarti F; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2012 Jan; 80(1):95-102. PubMed ID: 21964316
[TBL] [Abstract][Full Text] [Related]
3. Development and in vivo evaluation of an oral vitamin B12 delivery system.
Sarti F; Müller C; Iqbal J; Perera G; Laffleur F; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2013 May; 84(1):132-7. PubMed ID: 23262165
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles.
Mo R; Jin X; Li N; Ju C; Sun M; Zhang C; Ping Q
Biomaterials; 2011 Jul; 32(20):4609-20. PubMed ID: 21440934
[TBL] [Abstract][Full Text] [Related]
5. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.
Varma MV; Panchagnula R
Eur J Pharm Sci; 2005; 25(4-5):445-53. PubMed ID: 15890503
[TBL] [Abstract][Full Text] [Related]
6. Pluronic-poly (acrylic acid)-cysteine/Pluronic L121 mixed micelles improve the oral bioavailability of paclitaxel.
Zhao Y; Li Y; Ge J; Li N; Li LB
Drug Dev Ind Pharm; 2014 Nov; 40(11):1483-93. PubMed ID: 23971495
[TBL] [Abstract][Full Text] [Related]
7. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
Palmberger TF; Hombach J; Bernkop-Schnürch A
Int J Pharm; 2008 Feb; 348(1-2):54-60. PubMed ID: 17716840
[TBL] [Abstract][Full Text] [Related]
8. Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats.
Choi JS; Jo BW
Int J Pharm; 2004 Aug; 280(1-2):221-7. PubMed ID: 15265561
[TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of thiolated poly(acrylic acid) as a drug absorption modulator for MRP2 efflux pump substrates.
Greindl M; Föger F; Hombach J; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2009 Aug; 72(3):561-6. PubMed ID: 19344758
[TBL] [Abstract][Full Text] [Related]
10. Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(s)-ginsenoside Rg3 in vivo.
Yang LQ; Wang B; Gan H; Fu ST; Zhu XX; Wu ZN; Zhan DW; Gu RL; Dou GF; Meng ZY
Biopharm Drug Dispos; 2012 Nov; 33(8):425-36. PubMed ID: 22898996
[TBL] [Abstract][Full Text] [Related]
11. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.
Föger F; Hoyer H; Kafedjiiski K; Thaurer M; Bernkop-Schnürch A
Biomaterials; 2006 Dec; 27(34):5855-60. PubMed ID: 16919723
[TBL] [Abstract][Full Text] [Related]
12. Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats.
Park JH; Park JH; Hur HJ; Woo JS; Lee HJ
Eur J Pharm Sci; 2012 Feb; 45(3):296-301. PubMed ID: 22172604
[TBL] [Abstract][Full Text] [Related]
13. Effect of a thiolated polymer on oral paclitaxel absorption and tumor growth in rats.
Föger F; Malaivijitnond S; Wannaprasert T; Huck C; Bernkop-Schnürch A; Werle M
J Drug Target; 2008 Feb; 16(2):149-55. PubMed ID: 18274935
[TBL] [Abstract][Full Text] [Related]
14. The ethanol metabolite acetaldehyde increases paracellular drug permeability in vitro and oral bioavailability in vivo.
Fisher SJ; Swaan PW; Eddington ND
J Pharmacol Exp Ther; 2010 Jan; 332(1):326-33. PubMed ID: 19820208
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel.
Kimura Y; Aoki J; Kohno M; Ooka H; Tsuruo T; Nakanishi O
Cancer Chemother Pharmacol; 2002 Apr; 49(4):322-8. PubMed ID: 11914912
[TBL] [Abstract][Full Text] [Related]
16. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability.
Gao P; Rush BD; Pfund WP; Huang T; Bauer JM; Morozowich W; Kuo MS; Hageman MJ
J Pharm Sci; 2003 Dec; 92(12):2386-98. PubMed ID: 14603484
[TBL] [Abstract][Full Text] [Related]
17. Effects of silibinin, inhibitor of CYP3A4 and P-glycoprotein in vitro, on the pharmacokinetics of paclitaxel after oral and intravenous administration in rats.
Lee CK; Choi JS
Pharmacology; 2010; 85(6):350-6. PubMed ID: 20523105
[TBL] [Abstract][Full Text] [Related]
18. Poly(acrylic acid)-cysteine for oral vitamin B12 delivery.
Sarti F; Iqbal J; Müller C; Shahnaz G; Rahmat D; Bernkop-Schnürch A
Anal Biochem; 2012 Jan; 420(1):13-9. PubMed ID: 21964499
[TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
Föger F; Schmitz T; Bernkop-Schnürch A
Biomaterials; 2006 Aug; 27(23):4250-5. PubMed ID: 16618504
[TBL] [Abstract][Full Text] [Related]
20. The influence of enaminones on the transport and oral bioavailability of P-glycoprotein substrate therapeutic agents.
Salama NN; Scott KR; Eddington ND
Int J Pharm; 2004 Apr; 273(1-2):135-47. PubMed ID: 15010138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
